Business Wire - Lannett Company Receives Approval for Danazol
April 23, 2007 -- PHILADELPHIA -- Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approval from the...
Journal of Drugs in Dermatology - Severe refractory cholinergic urticaria treated with danazol
July 1, 2006 -- Abstract Background: Cholinergic urticaria is a form of physical urticaria triggered by a rise in core body temperature. Antihistamines are the...
Internal Medicine News - Intravaginal danazol allayed endometrial pain
November 1, 2004 -- CHICAGO -- A novel formulation of intravaginal danazol significantly reduces chronic pelvic pain in women with endometriosis, Thomas Janicki, M.D.,...
OB/GYN News - Intravaginal danazol gel acts locally to relieve endometriosis pain
October 1, 2004 -- CHICAGO -- A novel formulation of intravaginal danazol significantly reduced chronic pelvic pain in a small study of women with endometriosis, Dr....
Internal Medicine News - ESAs may boost leukemia risk in myelofibrosis: retrospective analysis shows association
January 15, 2008 -- ATLANTA -- Physicians at the Mayo Clinic in Rochester, Minn., stopped giving erythropoietic-stimulating agents to patients with primary myelofibrosis...
Adverse Event Reporting News - Mayo clinic study links anemia drugs to leukemia risk
December 17, 2007 -- Anemia drugs from Amgen and Johnson & Johnson may raise the risk that patients with a bone marrow disease will later develop leukemia, according...
OB/GYN News - Danazol may be linked to rise in ovarian cancer, small study finds - Risk raised two-to threefold
September 1, 2002 -- MIAMI BEACH--Danazol use may be associated with increased risk for ovarian cancer, the results of a small study suggest. In the study, which...
Business Wire - An Overview of the European Endometriosis Therapeutics Market
July 18, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c63062) has announced the addition of the Frost & Sullivan...
Chain Drug Review - New products ready to hit the market
May 21, 2007 -- WASHINGTON -- Barr Laboratories Inc. has received Food and Drug Administration approval to manufacture a generic version of Nimotop, a medication...
